FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2801591490> ?p ?o ?g. }

• W2801591490 endingPage "1849" @default.
• W2801591490 startingPage "1839" @default.
• W2801591490 abstract "Background: Coronary heart disease (CHD) is a leading cause of death globally. Although therapy with statins decreases circulating levels of low-density lipoprotein cholesterol and the incidence of CHD, additional events occur despite statin therapy in some individuals. The genetic determinants of this residual cardiovascular risk remain unknown. Methods: We performed a 2-stage genome-wide association study of CHD events during statin therapy. We first identified 3099 cases who experienced CHD events (defined as acute myocardial infarction or the need for coronary revascularization) during statin therapy and 7681 controls without CHD events during comparable intensity and duration of statin therapy from 4 sites in the Electronic Medical Records and Genomics Network. We then sought replication of candidate variants in another 160 cases and 1112 controls from a fifth Electronic Medical Records and Genomics site, which joined the network after the initial genome-wide association study. Finally, we performed a phenome-wide association study for other traits linked to the most significant locus. Results: The meta-analysis identified 7 single nucleotide polymorphisms at a genome-wide level of significance within the LPA/PLG locus associated with CHD events on statin treatment. The most significant association was for an intronic single nucleotide polymorphism within LPA/PLG (rs10455872; minor allele frequency, 0.069; odds ratio, 1.58; 95% confidence interval, 1.35–1.86; P =2.6×10 − 10 ). In the replication cohort, rs10455872 was also associated with CHD events (odds ratio, 1.71; 95% confidence interval, 1.14–2.57; P =0.009). The association of this single nucleotide polymorphism with CHD events was independent of statin-induced change in low-density lipoprotein cholesterol (odds ratio, 1.62; 95% confidence interval, 1.17–2.24; P =0.004) and persisted in individuals with low-density lipoprotein cholesterol ≤70 mg/dL (odds ratio, 2.43; 95% confidence interval, 1.18–4.75; P =0.015). A phenome-wide association study supported the effect of this region on coronary heart disease and did not identify noncardiovascular phenotypes. Conclusions: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering. This finding provides support for exploring strategies targeting circulating concentrations of lipoprotein(a) to reduce CHD events in patients receiving statins." @default.
• W2801591490 created "2018-05-17" @default.
• W2801591490 creator A5000163164 @default.
• W2801591490 creator A5001227060 @default.
• W2801591490 creator A5004181807 @default.
• W2801591490 creator A5004289607 @default.
• W2801591490 creator A5007540286 @default.
• W2801591490 creator A5009326615 @default.
• W2801591490 creator A5009328116 @default.
• W2801591490 creator A5013697180 @default.
• W2801591490 creator A5017961709 @default.
• W2801591490 creator A5018427711 @default.
• W2801591490 creator A5020730826 @default.
• W2801591490 creator A5028895480 @default.
• W2801591490 creator A5035154676 @default.
• W2801591490 creator A5036388273 @default.
• W2801591490 creator A5040375728 @default.
• W2801591490 creator A5040770914 @default.
• W2801591490 creator A5045892464 @default.
• W2801591490 creator A5048459234 @default.
• W2801591490 creator A5052880095 @default.
• W2801591490 creator A5053670656 @default.
• W2801591490 creator A5054315152 @default.
• W2801591490 creator A5058141203 @default.
• W2801591490 creator A5059340927 @default.
• W2801591490 creator A5065025844 @default.
• W2801591490 creator A5068255027 @default.
• W2801591490 creator A5068754205 @default.
• W2801591490 creator A5070908224 @default.
• W2801591490 creator A5072877214 @default.
• W2801591490 creator A5074148505 @default.
• W2801591490 creator A5081769614 @default.
• W2801591490 creator A5082819294 @default.
• W2801591490 creator A5088017777 @default.
• W2801591490 creator A5088183118 @default.
• W2801591490 date "2018-10-23" @default.
• W2801591490 modified "2023-10-14" @default.
• W2801591490 title "<i>LPA</i> Variants Are Associated With Residual Cardiovascular Risk in Patients Receiving Statins" @default.
• W2801591490 cites W1533942137 @default.
• W2801591490 cites W176696043 @default.
• W2801591490 cites W191029809 @default.
• W2801591490 cites W1969208427 @default.
• W2801591490 cites W1988163135 @default.
• W2801591490 cites W2006776184 @default.
• W2801591490 cites W2017283757 @default.
• W2801591490 cites W2021085462 @default.
• W2801591490 cites W2027867013 @default.
• W2801591490 cites W2036420216 @default.
• W2801591490 cites W2044515472 @default.
• W2801591490 cites W2048070048 @default.
• W2801591490 cites W2054539038 @default.
• W2801591490 cites W2063259781 @default.
• W2801591490 cites W2064043401 @default.
• W2801591490 cites W2064337796 @default.
• W2801591490 cites W2073920934 @default.
• W2801591490 cites W2074122841 @default.
• W2801591490 cites W2079979713 @default.
• W2801591490 cites W2080960856 @default.
• W2801591490 cites W2091052977 @default.
• W2801591490 cites W2092590432 @default.
• W2801591490 cites W2098230963 @default.
• W2801591490 cites W2099344975 @default.
• W2801591490 cites W2102215872 @default.
• W2801591490 cites W2104549677 @default.
• W2801591490 cites W2104689123 @default.
• W2801591490 cites W2105714645 @default.
• W2801591490 cites W2108169091 @default.
• W2801591490 cites W2111307685 @default.
• W2801591490 cites W2114951165 @default.
• W2801591490 cites W2117356702 @default.
• W2801591490 cites W2133520037 @default.
• W2801591490 cites W2137983259 @default.
• W2801591490 cites W2140072878 @default.
• W2801591490 cites W2149791927 @default.
• W2801591490 cites W2157752701 @default.
• W2801591490 cites W2161633633 @default.
• W2801591490 cites W2164089346 @default.
• W2801591490 cites W2169555151 @default.
• W2801591490 cites W2169920876 @default.
• W2801591490 cites W2196906371 @default.
• W2801591490 cites W2200285648 @default.
• W2801591490 cites W2209106767 @default.
• W2801591490 cites W2247997571 @default.
• W2801591490 cites W2274048411 @default.
• W2801591490 cites W2409616352 @default.
• W2801591490 cites W2428945005 @default.
• W2801591490 cites W2462534046 @default.
• W2801591490 cites W2538126758 @default.
• W2801591490 cites W2586892149 @default.
• W2801591490 cites W2596179513 @default.
• W2801591490 cites W2596236174 @default.
• W2801591490 cites W2613818970 @default.
• W2801591490 cites W2728065598 @default.
• W2801591490 cites W2765332076 @default.
• W2801591490 cites W3001764054 @default.
• W2801591490 cites W3190912488 @default.
• W2801591490 doi "https://doi.org/10.1161/circulationaha.117.031356" @default.
• W2801591490 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6202211" @default.

• next